Your browser doesn't support javascript.
loading
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'.
Veenstra, Jesse; Wang, Jie; McKinnon-Maksimowicz, Kathleen; Liu, Tingting; Zuniga, Bobby; Hamzavi, Iltefat; Zhou, Li; Mi, Qing-Sheng.
Afiliación
  • Veenstra J; Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA.
  • Wang J; Center for Cutaneous Biology and Immunology, Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA.
  • McKinnon-Maksimowicz K; Immunology Program, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Liu T; Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA.
  • Zuniga B; Center for Cutaneous Biology and Immunology, Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA.
  • Hamzavi I; Immunology Program, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Zhou L; Division of Rheumatology, Department of Internal Medicine, Henry Ford Health System, Detroit, Michigan, USA.
  • Mi QS; Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA.
Ann Rheum Dis ; 80(10): e160, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34112654

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Terapia de Inmunosupresión / Vacunas contra la COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Terapia de Inmunosupresión / Vacunas contra la COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos